Abstract
HSV-1 amplicon vectors have been used as platforms for the generation of genetic vaccines against both DNA and RNA viruses. Mice vaccinated with such vectors encoding structural proteins from both foot-and-mouth disease virus and rotavirus were partially protected from challenge with wild-type virus (D’Antuono et al. Vaccine 28: 7363–7372, 2010; Laimbacher et al. Mol Ther 20: 1810–1820, 2012), indicating that HSV-1 amplicon vectors are attractive tools for the development of complex and safe genetic vaccines. This chapter describes the use of HSV-1 amplicon vectors that encode individual or multiple viral structural proteins from a polycistronic transgene cassette in mammalian cells. More precisely, amplicon vectors that encode multiple structural viral proteins support the in situ production of viruslike particles (VLPs) in vector-infected cells. The expression of the viral genes is confirmed by Western blot and immune fluorescence analysis, and the generation of VLPs in vector-infected cells is demonstrated by electron microscopy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
D'Antuono A, Laimbacher AS, La Torre J et al (2010) HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization. Vaccine 28:7363–7372
Laimbacher AS, Esteban LE, Castello AA et al (2012) HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice. Mol Ther 20:1810–1820
de Silva S, Bowers WJ (2009) Herpes virus amplicon vectors. Viruses 1:594–629
Parrish E, Peltekian E, Dickson G et al (1999) Cell engineering for muscle gene therapy: extemporaneous production of retroviral vector packaging macrophages using defective herpes simplex virus type 1 vectors harbouring gag, pol, env genes. Cytotechnology 30:173–180
Sena-Esteves M, Saeki Y, Camp SM et al (1999) Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. J Virol 73:10426–10439
Saeki Y, Fraefel C, Ichikawa T et al (2001) Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther 3:591–601
Smith IL, Hardwicke MA, Sandri-Goldin RM (1992) Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186:74–86
Saeki Y, Ichikawa T, Saeki A et al (1998) Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther 9:2787–2794
McGeoch DJ, Dalrymple MA, Davison AJ et al (1988) The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 69:1531–1574
Coffin SE, Moser CA, Cohen S et al (1997) Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice. J Virol 71:7851–7856
Ward RL, McNeal MM, Sheridan JF (1990) Development of an adult mouse model for studies on protection against rotavirus. J Virol 64:5070–5075
Gray J, Desselberger U (2000) Rotaviruses: methods and protocols. Humana, New York
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Laimbacher, A.S., Fraefel, C. (2014). HSV-1 Amplicon Vectors as Genetic Vaccines. In: Diefenbach, R., Fraefel, C. (eds) Herpes Simplex Virus. Methods in Molecular Biology, vol 1144. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0428-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0428-0_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0427-3
Online ISBN: 978-1-4939-0428-0
eBook Packages: Springer Protocols